Gain Therapeutics Inc (GANX) Price Prediction & ForecastGANXGain Therapeutics Inc

Alphio's GANX stock price prediction model matches the current Gain Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.75 (-0.98%). The 1-week path is $1.79 (+1.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Gain Therapeutics Inc (GANX) is trading at $1.77, significantly below the analyst price target of $8, indicating potential upside. However, the stock has a low RSI of 28.169, suggesting it is oversold. The company reported a narrower Q2 loss of $4.67 million, which is an improvement from the previous year's loss of $5.81 million, indicating better cost management. The main risk is the ongoing negative net income, with a total of -$5.6 million reported in Q1 2026, which raises concerns about long-term sustainability.

Gain Therapeutics Inc (GANX) last closed at $1.77, losing -4.32%. These facts feed the 1-day and 1-week GANX price prediction above.